OBJECTIVE: The aim of this study was to assess the potential of perfusion computed tomography (CTp) for monitoring induction chemotherapy in patients with squamous cell carcinoma (SCCA) of the upper aerodigestive tract. MATERIALS AND METHODS: Twenty-five patients with advanced SCCA underwent CTp and volumetric CT before and after induction chemotherapy. Perfusion CT parameters were calculated in the tumor, normal tissue, and muscles and correlated with tumor volume. RESULTS: The blood flow (BF), blood volume (BV), and permeability surface were significantly higher, and the mean transit time was significantly lower in the tumor than in the normal tissue. The tumor BF and BV significantly decreased, and the mean transit time significantly increased after the therapy; decrease in BF and BV correlated with tumor volume reduction after chemotherapy. The baseline tumor BV was significantly lower in nonresponders compared with that in responders. CONCLUSIONS: In patients with SCCA, CTp showed potential for monitoring induction chemotherapy, reduction in tumor BF and BV correlated with reduction of tumor volume after chemotherapy, and baseline tumor BV may predict response to chemotherapy.
OBJECTIVE: The aim of this study was to assess the potential of perfusion computed tomography (CTp) for monitoring induction chemotherapy in patients with squamous cell carcinoma (SCCA) of the upper aerodigestive tract. MATERIALS AND METHODS: Twenty-five patients with advanced SCCA underwent CTp and volumetric CT before and after induction chemotherapy. Perfusion CT parameters were calculated in the tumor, normal tissue, and muscles and correlated with tumor volume. RESULTS: The blood flow (BF), blood volume (BV), and permeability surface were significantly higher, and the mean transit time was significantly lower in the tumor than in the normal tissue. The tumor BF and BV significantly decreased, and the mean transit time significantly increased after the therapy; decrease in BF and BV correlated with tumor volume reduction after chemotherapy. The baseline tumor BV was significantly lower in nonresponders compared with that in responders. CONCLUSIONS: In patients with SCCA, CTp showed potential for monitoring induction chemotherapy, reduction in tumor BF and BV correlated with reduction of tumor volume after chemotherapy, and baseline tumor BV may predict response to chemotherapy.
Authors: Vicky Goh; Manu Shastry; Alec Engledow; Jonathan Reston; David M Wellsted; Jacqui Peck; Raymondo Endozo; Manuel Rodriguez-Justo; Stuart A Taylor; Steve Halligan; Ashley M Groves Journal: Eur Radiol Date: 2010-10-05 Impact factor: 5.315
Authors: Sonia P Li; Andreas Makris; Andrew Gogbashian; Ian C Simcock; J James Stirling; Vicky Goh Journal: Eur Radiol Date: 2012-04-17 Impact factor: 5.315
Authors: Amy Sun; Lewis Hou; Tiffany Prugpichailers; Jason Dunkel; Maziyar A Kalani; Xiaoyuan Chen; M Yashar S Kalani; Victor Tse Journal: Neurosurgery Date: 2010-04 Impact factor: 4.654
Authors: Dominik Ketelsen; Marius Horger; Markus Buchgeister; Michael Fenchel; Christoph Thomas; Nadine Boehringer; Maximilian Schulze; Ilias Tsiflikas; Claus D Claussen; Martin Heuschmid Journal: Korean J Radiol Date: 2010-08-27 Impact factor: 3.500
Authors: K A Miles; T-Y Lee; V Goh; E Klotz; C Cuenod; S Bisdas; A M Groves; M P Hayball; R Alonzi; T Brunner Journal: Eur Radiol Date: 2012-02-26 Impact factor: 5.315